Pegvisomant
Pharmaceutical drug / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Pegvisomant?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Pegvisomant, sold under the brand name Somavert, is a growth hormone receptor antagonist used in the treatment of acromegaly.[1][2][3] It is primarily used if the pituitary gland tumor causing the acromegaly cannot be controlled with surgery or radiation, and the use of somatostatin analogues is unsuccessful, but is also effective as a monotherapy.[4] It is delivered as a powder that is mixed with water and injected under the skin.[5]
Quick Facts Clinical data, Trade names ...
Clinical data | |
---|---|
Trade names | Somavert |
AHFS/Drugs.com | Monograph |
License data |
|
Pregnancy category |
|
Routes of administration | Subcutaneous |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
CAS Number | |
IUPHAR/BPS | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
Chemical and physical data | |
Formula | C990H1532N262O300S7 |
Molar mass | 22129.10 g·mol−1 |
NY (what is this?) (verify) |
Close